Patents by Inventor Henrik Sandberg

Henrik Sandberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220361794
    Abstract: A dry electrode for biometric measurement on a skin and a method for manufacturing are disclosed. The dry electrode has a substrate forming the scaffold of the dry electrode. The substrate has metal or semiconductor material; an electrically conductive film on a first surface of the substrate; and an attaching element for attaching the dry electrode. The electrically conductive film is directly deposited on the first surface of the substrate. The electrically conductive film is a graphene film.
    Type: Application
    Filed: July 19, 2022
    Publication date: November 17, 2022
    Inventors: Teemu RUOTSALAINEN, Tomi MATTILA, Henrik SANDBERG, Wonjae KIM, Sanna ARPIAINEN, Colm MCCAFFREY
  • Publication number: 20210316992
    Abstract: According to an example aspect of the present invention, there is provided a method for producing graphene foam structures by assembling graphene or graphene oxide in a three-dimensional structure, wherein biomolecular surface active agents are used as a template in a water-based foam. The graphene foam structures produced by the method of the invention find industrial application for example in sensing and material applications.
    Type: Application
    Filed: April 26, 2019
    Publication date: October 14, 2021
    Inventors: Katri Kurppa, Arja Paananen, Geza Szilvay, Timo Pulli, Henrik Sandberg, Miika Soikkeli, Jukka Ketoja, Teemu Ruotsalainen
  • Patent number: 10479792
    Abstract: A compound of Formula (I), or a salt thereof, compositions comprising the compound, processes for its preparation and its use in therapy, for example in the treatment of parasitic diseases such as Chagas disease, Human African Trypanosomiasis (HAT), Animal African trypanosomiasis (AAT) and leishmaniasis, particularly visceral leishmaniasis (VL).
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: November 19, 2019
    Assignees: GiaxoSmithKline Intellectual Property Development Limited, University of Dundee
    Inventors: Stephen Brand, Peter George Dodd, Eun Jung Ko, Maria Marco Martin, Timothy James Miles, Lars Henrik Sandberg, Michael George Thomas, Stephen Thompson
  • Patent number: 10065965
    Abstract: A compound of Formula (I), or a salt thereof, compositions comprising the compound, processes for its preparation and its use in therapy, for example in the treatment of parasitic diseases such as Chagas disease, Human African Trypanosomiasis (HAT) and leishmaniasis, particularly visceral leishmaniasis (VL).
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: September 4, 2018
    Assignees: GlaxoSmithKline Intellectual Property Development Limited, The University of Dundee
    Inventors: Stephen Brand, Elisabet Viayna Gaza, Ian Gilbert, Eun Jung Ko, Maria Marco Martin, Timothy James Miles, Lars Henrik Sandberg, Michael George Thomas
  • Publication number: 20180222911
    Abstract: A compound of Formula (I), or a salt thereof, compositions comprising the compound, processes for its preparation and its use in therapy, for example in the treatment of parasitic diseases such as Chagas disease, Human African Trypanosomiasis (HAT), Animal African trypanosomiasis (AAT) and leishmaniasis, particularly visceral leishmaniasis (VL).
    Type: Application
    Filed: August 3, 2016
    Publication date: August 9, 2018
    Inventors: Stephen BRAND, Peter George DODD, Eun Jung KO, Maria MARCO MARTIN, Timothy James MILES, Lars Henrik SANDBERG, Michael George THOMAS, Stephen THOMPSON
  • Publication number: 20180141949
    Abstract: A compound of Formula (I), or a salt thereof, compositions comprising the compound, processes for its preparation and its use in therapy, for example in the treatment of parasitic diseases such as Chagas disease, Human African Trypanosomiasis (HAT) and leishmaniasis, particularly visceral leishmaniasis (VL).
    Type: Application
    Filed: May 26, 2016
    Publication date: May 24, 2018
    Inventors: Stephen BRAND, Elisabet Viayna GAZA, Ian GILBERT, Eun Jung KO, Maria MARCO MARTIN, Timothy James MILES, Lars Henrik SANDBERG, Michael George THOMAS
  • Patent number: 7922986
    Abstract: A reagent cup device 1 includes a plurality of individually sealed reagent cup compartments 7, each holding a reagent cup 8 having an open end and an inner surface, at least part of which is coated with a chemical reagent. Each reagent cup compartment 7 is closed and has a first end covered by a first breakable seal 5 and a second end covered by a second breakable seal 10. Since the reagent cup compartments 7 are individually sealed by the breakable seals 5, 10, it is possible to gain access to the interior of a reagent cup compartment 7, and thereby to the reagent cup 8 held therein, without breaking the sealing of the remaining reagent cup compartments 7. Thereby degradation of the chemical reagent in the reagent cups 8 is reduced, and the expected lifetime of the reagent cups 8 is accordingly increased. The breakable seals 5, 10 may be provided with weakened zones in order to easier break the seals 5, 10 when access is desired.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: April 12, 2011
    Assignee: Radiometer Medical ApS
    Inventors: Allan Byrnard, Henrik Sandberg
  • Publication number: 20080226508
    Abstract: A reagent cup device 1 includes a plurality of individually sealed reagent cup compartments 7, each holding a reagent cup 8 having an open end and an inner surface, at least part of which is coated with a chemical reagent. Each reagent cup compartment 7 is closed and has a first end covered by a first breakable seal 5 and a second end covered by a second breakable seal 10. Since the reagent cup compartments 7 are individually sealed by the breakable seals 5, 10, it is possible to gain access to the interior of a reagent cup compartment 7, and thereby to the reagent cup 8 held therein, without breaking the sealing of the remaining reagent cup compartments 7. Thereby degradation of the chemical reagent in the reagent cups 8 is reduced, and the expected lifetime of the reagent cups 8 is accordingly increased. The breakable seals 5, 10 may be provided with weakened zones in order to easier break the seals 5, 10 when access is desired.
    Type: Application
    Filed: March 14, 2008
    Publication date: September 18, 2008
    Inventors: Allan Byrnard, Henrik Sandberg